Kanna (Sceletium Tortuosum): The Natural Mood Booster You Should Know

What Is Kanna?

Sceletium tortuosum is a small succulent plant native to the arid Namaqualand and Karoo regions of South Africa. It belongs to the Aizoaceae family — the same group as living stones (Lithops) and ice plants. In the wild it produces small yellow flowers, but it's the dried and fermented plant material that has been traded and used for centuries.

The name "kanna" comes from the San people of southern Africa. The Khoikhoi called it kougoed — Afrikaans for "chewing substance" — because chewing fermented plant material was the most traditional preparation method. Dutch settlers who arrived in South Africa in the 17th and 18th centuries documented its use extensively. The botanist Carl Peter Thunberg noted in 1773 that the Khoikhoi used it to "quiet the mind" during long journeys. Returning warriors reportedly used it to decompress after battle.

Traditional preparation involved fermenting the freshly harvested plant in the sun for several days, which transforms the alkaloid profile and produces the characteristic psychoactive effects. The fermented material was then chewed, smoked, used as a nasal snuff, or brewed into tea.

Today, Kanna is commercially cultivated in South Africa, available in standardised extracts, and sold legally throughout the Netherlands and most of Europe as a smartshop product.

---

How Does Kanna Work?

Kanna's pharmacology is better understood than most herbal supplements. Its key alkaloids — primarily mesembrine and mesembrenone — act through two complementary mechanisms.

Serotonin Reuptake Inhibition (SRI)

Mesembrine functions as a natural serotonin reuptake inhibitor, the same basic mechanism used by pharmaceutical SSRIs like fluoxetine (Prozac) and escitalopram. By blocking the transporter that removes serotonin from synapses, it increases serotonin availability in the brain — producing mood elevation, reduced anxiety, and a sense of emotional ease.

The key difference from pharmaceutical SSRIs is speed of onset. SSRIs take 2–6 weeks to produce clinical effects because they work through long-term receptor adaptation. Kanna, taken sublingually or as a snuff, can produce noticeable effects within minutes — because it's working acutely at the synapse rather than triggering receptor downregulation processes.

PDE4 Inhibition

Mesembrenone inhibits phosphodiesterase-4 (PDE4), an enzyme that breaks down cyclic AMP (cAMP) — a signalling molecule critical for memory, learning, and neuroplasticity. PDE4 inhibitors are actively researched as treatments for depression, cognitive decline, and neuroinflammation. This mechanism explains Kanna's reported cognitive effects: mild enhancement of focus, mental clarity, and information processing, particularly at lower doses.

The combination of SRI and PDE4 inhibition is pharmacologically unusual — most mood-affecting compounds work through one mechanism or the other. Kanna's dual action is part of what makes it interesting to researchers.

---

Effects and Benefits

At typical doses, Kanna produces a distinctive profile that users describe as calmer and warmer than stimulants, without the sedation of benzodiazepines or the dissociation of heavier psychedelics.

At low doses (25–100mg dried herb equivalent):

• Mood elevation — a gentle lift without euphoric overreach
• Anxiety reduction — less social tension, easier conversation
• Mental clarity — reduced cognitive noise, mild focus enhancement
• Empathogenic quality — slightly heightened appreciation for social connection and surroundings

At higher doses (200–500mg+ dried herb equivalent):

• Deeper relaxation
• Mild euphoria
• Some users report enhanced sensory appreciation
• Sedation becomes more pronounced

Anecdotally, Kanna has built a following in the Netherlands particularly as an alcohol alternative — used at social events and festivals for its sociability-enhancing effects without the next-day hangover. This matches its traditional social use pattern closely.

Research suggests Kanna's effects are best described as anxiolytic-empathogenic rather than psychedelic in the classical sense. At standard doses, it doesn't produce visuals, dissociation, or perceptual distortion.

---

What Does the Research Say?

The human evidence base for Kanna is modest but meaningful, centred primarily on the standardised extract Zembrin®.

The Terburg 2013 Amygdala Study

The most cited human trial (Terburg et al., 2013, published in Neuropsychopharmacology) used a placebo-controlled, double-blind crossover design with 16 healthy participants. Subjects received a single dose of Zembrin® (25mg) or placebo, then completed tasks measuring threat-related amygdala reactivity while undergoing fMRI.

Zembrin® significantly reduced amygdala activation in response to threatening stimuli, and weakened connectivity between the amygdala and the hypothalamus — the pathway that drives the physiological stress response. This provides direct neuroimaging evidence for Kanna's anxiolytic mechanism in humans.

The 2013 Safety and Tolerability Trial

Nell et al. (2013) conducted a 3-month clinical study examining daily intake of 8mg and 25mg Zembrin® in healthy adults. No significant changes were observed in vital signs, liver function, kidney function, or ECG readings. The extract was well tolerated across the study period.

The 2025 Preclinical Chronic Stress Study

A July 2025 paper published in Cells (Zembrin® in Wistar rats subjected to 8 weeks of unpredictable chronic mild stress) found that both Zembrin® and isolated mesembrine reversed stress-induced anhedonia, anxiety behaviours, and neuroinflammatory markers in male rats. Effects were comparable to escitalopram — a commonly prescribed SSRI. The study noted reversal of hippocampal PDE4B overexpression and restoration of cortical serotonin levels.

This is preclinical data, and the jump from rats to humans requires caution. But the mechanistic clarity and the direct comparison with a pharmaceutical benchmark make it notable.

Honest Assessment

The human clinical trial database for Kanna is still thin compared to ashwagandha or St John's Wort. Most rigorous studies use Zembrin® specifically, meaning results may not fully generalise to other extracts or the dried herb. What exists is promising and mechanistically coherent — but claims should be proportionate to the evidence. This is an emerging field, not a settled one.

---

Kanna vs SSRIs: Understanding the Comparison

The SRI mechanism inevitably invites comparison to pharmaceutical antidepressants. It's worth being precise about this.

The critical point: Kanna is not a replacement for prescribed antidepressants or anxiety medication. If you are being treated for depression or anxiety with medication, do not add Kanna without discussing it with your prescriber. The interaction risks are real and serious (see Safety section below).

Kanna is better understood as a legal, plant-based mood tool for recreational use, occasional stress relief, or social enhancement — not as self-medication for clinical mental health conditions.

---

Forms and Dosage

Kanna is available in several forms, each with different potency, onset speed, and appropriate use cases.

Start low. If you're new to Kanna, begin with 50–100mg of the dried herb sublingually or as tea. Assess your response before increasing. Individual sensitivity varies considerably, and the gap between a pleasant experience and an uncomfortable one narrows faster with extracts.

---

Kanna as a Social Supplement

One of the more interesting trends in the Dutch smartshop scene is the growing use of Kanna as a conscious alternative to alcohol at social events. Its empathogenic, anxiety-reducing profile makes it genuinely suited to this role — it lowers social inhibition and enhances presence without significant cognitive impairment or the dehydration, sleep disruption, and next-day effects of alcohol.

This maps almost exactly onto its traditional use. The San used Kanna communally — at celebrations, before social gatherings, and as part of ritual bonding. The modern rediscovery of this use case is culturally coherent rather than incidental.

It also appears in festival culture and the broader "mindful intoxicants" movement gaining traction in the Netherlands and beyond. For people looking to participate socially without alcohol, Kanna offers a pharmacologically meaningful option.

---

Quality and Sourcing

Not all Kanna products are equal — and the differences matter.

Chemotype variation: Wild Sceletium tortuosum plants naturally vary in alkaloid profile depending on geographic origin. A 2025 Stellenbosch University study found significant differences in neurotransmitter effects between extracts from plants grown in Touwsrivier vs De Rust — both in South Africa, but with meaningfully different alkaloid compositions. This is why standardised extracts offer more predictable effects than generic kanna powder.

Zembrin® vs other extracts: Zembrin® is the most researched standardised extract, with defined alkaloid ratios (mesembrenone + mesembrenol ≥60%, mesembrine ≤20%). Most clinical trials use this specific preparation. Other extracts — including Azarius's UC, UC2, ET2, and UB40 formats — use different extraction methods and alkaloid profiles tailored to specific use cases.

Fermentation: Traditional kougoed was fermented, which transforms alkaloid ratios. Modern commercial products vary in whether fermentation is part of the process. Fermented preparations tend to have a more complex experiential profile.

Sustainability: Wild Sceletium tortuosum has become increasingly scarce due to overharvesting. Reputable suppliers use cultivated plants from South African farms. Some producers have formal benefit-sharing agreements with San communities, acknowledging the indigenous origin of this knowledge.

---

Safety and Drug Interactions

Kanna's SRI mechanism creates serious interaction risks that must be understood clearly.

Do not combine Kanna with:

• SSRIs (fluoxetine, sertraline, escitalopram, paroxetine, etc.) — combining two SRI-active substances risks serotonin syndrome, a potentially dangerous condition characterised by agitation, confusion, rapid heart rate, high blood pressure, and in severe cases, seizures
• MAOIs (monoamine oxidase inhibitors) — including pharmaceutical MAOIs and natural ones such as Syrian rue, Banisteriopsis caapi, and passionflower — serious serotonin syndrome risk
• MDMA — MDMA causes massive serotonin release; adding an SRI creates compounding serotonin toxicity risk
• Other serotonergic compounds — St John's Wort, tramadol, triptans, lithium — all require caution

At standard doses, Kanna is generally well tolerated. The 3-month safety study found no concerning signals. Mild side effects occasionally reported include temporary headache, mild nausea, and transient increase in anxiety immediately after administration — typically resolving quickly.

Not recommended for: Pregnant or breastfeeding individuals (insufficient safety data); people with bipolar disorder; anyone under 18.

Legal status: Kanna is legal in the Netherlands and throughout most of Europe. It is not a controlled substance. Products cannot be shipped outside Europe by Azarius.

Affiliate disclosure: Smart Supplements may earn a commission on purchases made through partner links. This does not affect our editorial independence.

---

How to Try Kanna for the First Time

1. Confirm you're not on any SSRIs, MAOIs, or other serotonergic medication. This is non-negotiable.
2. Start with dried herb or a mild extract — not a concentrated snuff or ET2 product. Dried herb sublingually at 50–100mg is a reasonable starting point.
3. Chew slowly and hold under the tongue for 5–10 minutes before swallowing. Sublingual absorption is faster and more efficient.
4. Set and setting matter. Kanna's social qualities emerge most clearly in relaxed, low-pressure environments.
5. Wait before redosing. Allow 60–90 minutes to assess the full effect before considering more.
6. Avoid alcohol on the same occasion for your first experience — understand its effects cleanly before combining.
7. Don't use daily. Some tolerance development is possible; a few times per week maximum with off weeks is recommended.

---

Frequently Asked Questions

What does kanna feel like?

Most users describe a gentle mood lift, reduced social anxiety, and a warm, present quality to the experience. It's not euphoric in the way MDMA is, nor sedating like cannabis indica. Think of it as social ease — conversations feel more natural, the edges of stress soften, and there's mild mental clarity at lower doses.

Is kanna safe?

In controlled doses, without drug interactions, the safety profile looks good. The 3-month clinical trial found no concerning physiological markers. The serious risks are interaction-based — combining Kanna with SSRIs, MAOIs, or MDMA is genuinely dangerous. Used responsibly and alone, it appears to be relatively safe.

Is kanna addictive?

Not considered addictive at typical doses. There's no documented physical withdrawal syndrome. Some psychological habituation is possible with frequent heavy use, which is why occasional rather than daily use is recommended.

Is kanna legal in the Netherlands?

Yes. Kanna is legal in the Netherlands and most EU countries. It is not classified as a controlled substance.

How is kanna different from magic truffles or kratom?

Unlike magic truffles (which act on serotonin 5-HT2A receptors to produce perceptual changes) or kratom (which acts on opioid receptors), Kanna works through serotonin reuptake inhibition and PDE4 inhibition — a mechanism far closer to pharmaceutical antidepressants. This makes it less "psychedelic" and more "mood-toning" in character.

Can I combine kanna with adaptogens?

Kanna combines cautiously with non-serotonergic adaptogens like ashwagandha or Rhodiola rosea. Avoid any herbs with known serotonergic activity, including St John's Wort and griffonia/5-HTP.

---

The Bottom Line

Kanna occupies an unusual space: a plant with centuries of documented traditional use, a well-characterised pharmacological mechanism, and an emerging — if still limited — clinical evidence base. Its dual SRI and PDE4 inhibition gives it a credible profile for mood elevation, anxiety reduction, and mild cognitive enhancement.

It's not a pharmaceutical, and the comparison to SSRIs, while mechanistically interesting, should not be read as clinical equivalence. For responsible recreational use, social enhancement, or occasional stress relief — by someone not on serotonergic medication — it's one of the more pharmacologically coherent plants the smartshop world has to offer.

Understand the interactions. Start low. Respect the plant's history and the people it came from.

---

Further reading:

• What Are Adaptogens? A Guide to Nature's Stress Fighters
• Magic Truffles Explained: Effects, Dosage, and What to Expect
• What Are Nootropics? A Beginner's Guide
• Microdosing Psilocybin: The Complete Beginner's Guide

---

This content is for informational purposes only and is not medical advice. Consult a healthcare professional before starting any supplement. Do not use Kanna if you are taking SSRIs, MAOIs, or any other serotonergic medication.

Written by Smart Supplements Editorial Team Last updated: March 2026

Home / Blog / Smartshop